Inducible clindamycin resistance in Staphylococcus aureus isolates causing bacteremia at a university hospital in southern Taiwan

Diagnostic Microbiology and Infectious Disease

Volumn 58, Issue 2, 2007, Pages 203-209

  Janapatla, Rajendra Prasad ^a   Yan, Jing Jou ^b   Huang, Ay Huey ^b   Chen, Hung Mo ^b   Wu, Hsiu Mei ^a   Wu, Jiunn Jong ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Clindamycin; Erythromycin; Staphylococcus aureus

Indexed keywords

AMIKACIN; CEFALOTIN; CEFAZOLIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; LINEZOLID; OXACILLIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLONAL VARIATION; ERMA GENE; ERMC GENE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCUS AUREUS; TAIWAN; UNIVERSITY HOSPITAL;

BACTEREMIA; BACTERIAL PROTEINS; CLINDAMYCIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HOSPITALS, UNIVERSITY; HUMANS; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; OXACILLIN; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TAIWAN;

EID: 34249873804     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2006.12.016     Document Type: Article

References (40)

1. Appelbaum P.C. MRSA-the tip of the iceberg. Clin. Microbiol. Infect. 12 Suppl. 2 (2006) 3-10
2. Azap O.K., Arslan H., Timurkaynak F., Yapar G., Oruc E., and Gagir U. Incidence of inducible clindamycin resistance in staphylococci: first results from Turkey. Clin. Microbiol. Infect. 11 (2005) 582-584
3. Bell J.M., Turnidge J.D., and SENTRY APAC. High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa, results from SENTRY antimicrobial surveillance program, 1998-1999. Antimicrob. Agents Chemother. 46 (2002) 879-881
4. Biedenbach D.J., Moet G.J., and Jones R.N. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn. Microbiol. Infect. Dis. 50 (2004) 59-69
5. Chavez-Bueno S., Bozdogan B., Katz K., Bowlware K.L., Cushion N., Cavuoti D., Ahmad N., McCracken Jr. G.H., and Appelbaum P.C. Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas. Antimicrob. Agents Chemother. 49 (2005) 2283-2288
6. Chu G., Vollrath D., and Davis R.W. Separation of large DNA molecules by contour-clamped homogeneous electric fields. Science 234 (1986) 1582-1585
7. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; 16th Informational Supplement M100-S16 (2006), CLSI, Wayne, PA
8. Diekema D.J., Pfaller M.A., Schmitz F.J., Smayevsky J., Bell J., Jones R.N., Beach M., and SENTRY Participants Group. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 32 Suppl 2 (2001) 114-132
9. Fiebelkorn K.R., Crawford S.A., McElmeel M.L., and Jorgensen J.H. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J. Clin. Microbiol. 41 (2003) 4740-4744
10. Fluit A.C., Schmitz F.J., Verhoef J., and European SENTRY Participants. Multi-resistance to antimicrobial agents for the ten most frequently isolated bacterial pathogens. Int. J. Antimicrob. Agents 18 (2001) 147-160
11. Frank A.L., Marcinak J.F., Mangat P.D., Tjhio J.T., Kelkar S., Schreckenberger P.C., and Quinn J.P. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr. Infect. Dis. J. 21 (2002) 530-534
12. Hsueh P.R., Liu C.Y., and Luh K.T. Current status of antimicrobial resistance in Taiwan. Emerg. Infect. Dis. 8 (2002) 132-137
13. Huang A.H., Yan J.J., and Wu J.J. Rapid dissemination of Staphylococcus aureus with classic oxacillin resistance phenotype at a new university hospital. J. Hosp. Infect. 44 (2000) 309-315
14. Huang Y.C., Su L.H., Wu T.L., Liu C.E., Young T.G., Chen P.Y., Hseuh P.R., and Lin T.Y. Molecular epidemiology of clinical isolates of methicillin-resistant Staphylococcus aureus in Taiwan. J. Clin. Microbiol. 42 (2004) 307-310
15. Kloos W.E., and Bannerman T.L. Staphylococcus and Micrococcus spp. 5th ed. In: Murray P.R., Baron E.J., Pfaller M.A., Tenover F.C., and Yolken R.H. (Eds) (1995), American Society for Microbiology Press, Washington (DC) 282-298
16. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34 (2002) 482-492
17. Lewis II J.S., and Jorgensen J.H. Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned?. Clin. Infect. Dis. 40 (2005) 280-285
18. Lina G., Quaglia A., Reverdy M.E., Leclercq R., Vandenesch F., and Etienne J. Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci. Antimicrob. Agents Chemother. 43 (1999) 1062-1066
19. Martinez-Aguilar G., Hammerman W.A., Mason Jr. E.O., and Kaplan S.L. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr. Infect. Dis. J. 22 (2003) 593-598
20. McDonald L.C., Lauderdale T.L., Shiau Y.R., Chen P.C., Lai J.F., Wang H.Y., Ho M., and TSAR Participating Hospitals. The status of antimicrobial resistance in Taiwan among Gram-positive pathogens: the Taiwan Surveillance of Antimicrobial Resistance (TSAR) programme, 2000. Int. J. Antimicrob. Agents 23 (2004) 362-370
21. Munckhof W.J., Kleinschmidt S.L., and Schooneveldt J.M. Inducible clindamycin resistance in erythromycin-resistant, non-multiresistant, methicillin-resistant Staphylococcus aureus. Pathology 36 (2004) 373-374
22. Navaneeth B.V. A preliminary in vitro study on inducible and constitutive clindamycin resistance in Staphylococcus aureus from a South Indian tertiary care hospital. Int. J. Infect. Dis. 10 (2006) 184-185
23. Piggot P.J., Amjad M., Wu J.J., Sandoval H., and Castro J. Genetic and physical maps of Bacillus subtilis. In: Harwood C.R., and Cutting S.M. (Eds). Methods Biology Methods for Bacillus vol 168 (1990), John Wiley and Sons Ltd, West Sussex, England 493-543
24. Retsema J., and Fu W. Macrolides: structures and microbial targets. Int. J. Antimicrob. Agents 18 Suppl. 1 (2001) S3-S10
25. Roberts M.C., Sutcliffe J., Courvalin P., Jensen L.B., Rood J., and Seppala H. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob. Agents Chemother. 43 (1999) 2823-2830
26. Roberts R.B., de Lencastre A., Eisner W., Severina E.P., Shopsin B., Kreiswirth B.N., Tomasz A., and MRSA Collaborative Study Group. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in 12 New York hospitals. J. Infect. Dis. 178 (1998) 164-171
27. Ross J.I., Eady E.A., Cove J.H., Cunliffe W.J., Baumberg S., and Wootton J.C. Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol. Microbiol. 4 (1990) 1207-1214
28. Schmitz F.J., Sadurski R., Kray A., Boos M., Geisel R., Köhrer K., Verhoef J., and Fluit A.C. Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals. J. Antimicrob. Chemother. 45 (2000) 891-894
29. Schreckenberger P.C., Ilendo E., and Ristow K.L. Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and a tertiary care hospital. J. Clin. Microbiol. 42 (2004) 2777-2779
30. Siberry G.K., Tekle T., Carroll K., and Dick J. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin. Infect. Dis. 37 (2003) 1257-1260
31. Spiliopoulou I., Petinaki E., Papandreou P., and Dimitracopoulos G. erm(C) is the predominant genetic determinant for the expression of resistance to macrolides among methicillin-resistant Staphylococcus aureus clinical isolates in Greece. J. Antimicrob. Chemother. 53 (2004) 814-817
32. Stefani S., and Varaldo P.E. Epidemiology of methicillin-resistant staphylococci in Europe. Clin. Microbiol. Infect. 9 (2003) 1179-1186
33. Styers D., Sheehan D.J., Hogan P., and Sahm D.F. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus, 2005 status in the United States. Ann. Clin. Microbiol. Antimicrob. 5 (2006) 2
34. Tai P.W., Huang C.H., Lin Q.D., and Huang Y.Y. Molecular pattern and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus isolates at a teaching hospital in Northern Taiwan. J. Microbiol. Immunol. Infect. 39 (2006) 225-230
35. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., and Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33 (1995) 2233-2239
36. Townsend D.E., Ashdown N., Bolton S., Bradley J., Duckworth Moorhouse E.C., and Grubb W.B. The international spread of methicillin resistant Staphylococcus aureus. J. Hosp. Infect. 9 (1987) 60-71
37. Weisblum B. Inducible resistance to macrolides, lincosamides and streptogramin type B antibiotics, the resistance phenotype, its biological diversity, and structural elements that regulate expression-a review. J. Antimicrob. Chemother. 16 Suppl (1985) 63-90
38. Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob. Agents Chemother. 39 (1995) 577-585
39. Werckenthin C., Schwarz S., and Westh H. Structural alterations in the translational attenuator of constitutively expressed ermC genes. Antimicrob. Agents Chemother. 43 (1999) 1681-1685
40. Wu C.J., Lee H.C., Lee N.Y., Shih H.I., Ko N.Y., Wang L.R., and Ko W.C. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003. J. Microbiol. Immunol. Infect. 39 (2006) 135-143